Orthopedic Bone Cement Casting Materials Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The market encompasses materials used to immobilize fractures, anchor prosthetic joints, and augment vertebral compression fractures. Bone cement products, primarily based on polymethylmethacrylate (PMMA) and calcium-phosphate ceramics, are essential for securing implants during hip, knee, and shoulder arthroplasties. Casting materials including synthetic resin bandages, fiberglass tapes, and traditional plaster of Paris serve the broader orthopedic trauma and rehabilitation segment.

• •PMMA-based bone cements dominate the fixation segment, while newer bioactive cements incorporating calcium phosphates and glass-ceramics are gaining clinical adoption
• •The casting materials segment includes plaster of Paris bandages, fiberglass casting tapes, and thermoplastic splinting materials used in fracture management
• •Spinal augmentation procedures such as vertebroplasty and kyphoplasty represent a significant and growing application category

Rising prevalence of musculoskeletal disorders, particularly osteoporosis and osteoarthritis, is driving increased demand for joint replacement and vertebral augmentation procedures. The global trend toward road traffic accidents and falls, especially among aging populations, contributes to higher fracture incidence and subsequent casting needs. Favorable demographics, with the elderly population projected to reach 2.1 billion by 2050, ensure a sustained upward trajectory for orthopedic procedures.

• •Rising incidence of osteoporosis-related vertebral compression fractures is expanding the vertebroplasty and kyphoplasty market
• •Increasing volume of primary and revision hip and knee arthroplasty procedures globally, particularly in emerging markets
• •Advancements in minimally invasive surgical techniques are broadening the eligible patient pool for orthopedic interventions

The market is segmented by material type, product category, application, and end-user, with North America accounting for the largest share due to high procedure volumes and advanced healthcare infrastructure. Europe follows closely, supported by established reimbursement frameworks and aging populations. The Asia-Pacific region is emerging as the fastest-growing market, driven by healthcare infrastructure investments, rising medical tourism, and growing awareness of advanced orthopedic treatments.

• •Material segmentation includes PMMA bone cements, calcium phosphate and ceramic cements, acrylic blends and copolymers, and bioactive glass-based advanced materials
• •North America leads the market with strong adoption of premium products, while Europe and Japan represent mature, stable demand centers
• •Asia-Pacific, particularly China and India, is projected to grow at above-average rates due to expanding healthcare access and rising disposable incomes

What are the recent trends and outlook?

Antibiotic-impregnated bone cements are gaining prominence as surgical-site infection rates become a critical quality metric, while 3D-printed patient-specific implants paired with custom cement formulations represent the next frontier in personalized orthopedic care. The market is also seeing increased adoption of bioactive materials that promote osseointegration and reduce long-term loosening risk. Regulatory emphasis on product safety and clinical evidence requirements continues to shape product development priorities across manufacturers.

• •Growing clinical preference for antibiotic-loaded bone cements in primary and revision arthroplasty to reduce prosthetic joint infection rates
• •Development of calcium phosphate and glass-ceramic cements with bioactivity and osteoconductive properties for enhanced bone bonding
• •Emerging technologies including 3D-printed implants and smart casting materials with sensors for remote monitoring of fracture healing